Source: Martínez Martínez KI, Ojeda Aguilar YL, Robles Villarreal L and Paz Pérez MA (2023) Barriers to methamphetamine treatment seeking in residential centers in Aguascalientes, Mexico. Front. Psychol. 14:1193453. doi: 10.3389/fpsyg.2023.1193453 Introduction: In the Aguascalientes, most people who...

Source: Hossain, M.K.; Davidson, M.; Kypreos, E.; Feehan, J.; Muir, J.A.; Nurgali, K.; Apostolopoulos, V. Immunotherapies for the Treatment of Drug Addiction. Vaccines 2022, 10, 1778. https://doi.org/10.3390/vaccines10111778 Abstract Substance use disorders (SUD) are a serious public health concern...

Source: Substance Abuse and Mental Health Services Administration: Connecting Communities to Substance Use Services: Practical Approaches for First Responders. SAMHSA Publication No. PEP23-06-01-010. Rockville, MD: National Mental Health and Substance Use Policy Laboratory. Substance Abuse and...

Source: Austin EJ, Chen J, Briggs ES, et al. Integrating Opioid Use Disorder Treatment Into Primary Care Settings. JAMA Netw Open. 2023;6(8):e2328627. doi:10.1001/jamanetworkopen.2023.28627 Key Points Question What are multidisciplinary primary care team perspectives on barriers and facilitators to...

Source: Krupchanka, D., Formanek, T., Shield, K., Rehm, J., Heymans, M. W., Fleischmann, A., Degenhardt, L., Gawad, T., & Poznyak, V. (2022). International monitoring of capacity of treatment systems for alcohol and drug use disorders: Methodology of the Service Capacity Index for Substance Use...

Source: Cooper, L., Rosen, J.G., Zhang, L. et al. Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study. Harm Reduct J 20, 71 (2023). https://doi.org/10.1186/s12954-023-00793-y Abstract Background The COVID-19...

Source: Lieslehto J, Tiihonen J, Lähteenvuo M, Mittendorfer-Rutz E, Tanskanen A, Taipale H. Comparative Effectiveness of Pharmacotherapies for the Risk of Attempted or Completed Suicide Among Persons With Borderline Personality Disorder. JAMA Netw Open. 2023;6(6):e2317130. doi:10.1001...

Directorio IAFA mayo 2023, programas de prevención, tratamiento, rehabilitación y recursos comunitarios de problemas asociados al consumo de sustancias psicoactivas, Costa Rica. En Costa Rica existen normativas a través de las cuales se evalúan los programas. Por Decreto Ejecutivo, las que se...

Fuente: https://www.cdc.gov/stopoverdose/polysubstance-use/pdf/Spanish-Polysubstance-Factsheet-508.pdf ¿Qué es el uso de múltiples sustancias? El uso de más de una droga, lo que se conoce como uso de múltiples sustancias, es frecuente. Esto incluye cuando se toman dos o más drogas al mismo tiempo o...

Source: https://www.cdc.gov/stopoverdose/polysubstance-use/pdf/Polysubstance-Use-Fact-Sheet_508.pdf What is polysubstance use? The use of more than one drug, also known as polysubstance use, is common. This includes when two or more are taken together or within a short time period, either...

El objetivo del Estándar es establecer las competencias básicas e indispensables en el ejercicio de la consejería en adicciones en nuestro país, principalmente las que se ejercen en establecimientos con modalidad residencial y que sirven de referente para el proceso de evaluación. Está integrado por...

Fuente: Taylor EA, Cantor JH, Bradford AC, Simon K, Stein BD. Tendencias en la dispensación de metadona para el trastorno por consumo de opioides después de los cambios en la política de pago de Medicare. JAMA Netw Open. 2023; 6(5):E2314328. doi:10.1001/jamanetworkopen.2023.14328 Puntos clave...

Source: Jakubowski, A., Singh-Tan, S., Torres-Lockhart, K. et al. Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation. Addict Sci Clin Pract 18, 31 (2023). https://doi.org/10.1186/s13722-023-00386-x Abstract...

Source: Jetelina KK, Molsberry RJ, Gonzalez JR, Beauchamp AM, Hall T. Prevalence of Mental Illness and Mental Health Care Use Among Police Officers. JAMA Netw Open. 2020;3(10):e2019658. doi:10.1001/jamanetworkopen.2020.19658 Key Points Question What is the prevalence of mental illness and mental...

Fuente: Organización Mundial de la Salud & Organización Panamericana de la Salud. (‎2011)‎. Intervención breve vinculada a ASSIST para el consumo riesgoso y nocivo de sustancias: manual para uso en la atención primaria. Organización Panamericana de la Salud. Este manual acompaña al documento La...

Source: Ware, O. D., Buresh, M. E., Irvin, N. A., Stitzer, M. L., & Sweeney, M. M. (2022). Factors related to substance use treatment attendance after peer recovery coach intervention in the emergency department. Drug and alcohol dependence reports, 5, 100093. Highlights •The emergency department...

Source: Duncan A, Stergiopoulos V, Dainty KN, et al. Community mental health funding, stakeholder engagement and outcomes: a realist synthesis. BMJ Open 2023;13:e063994. doi: 10.1136/bmjopen-2022-063994 Abstract Mental health services continues to be a high priority for healthcare and social service...

Source: Fleury, MJ., Cao, Z., Grenier, G. et al. Profiles of quality of outpatient care use, associated sociodemographic and clinical characteristics, and adverse outcomes among patients with substance-related disorders. Subst Abuse Treat Prev Policy 18, 5 (2023). https://doi.org/10.1186/s13011-022...

Source: Shapiro, C. J., Watson MacDonell, K., & Moran, M. (2021). Provider self-efficacy in delivering evidence-based psychosocial interventions: A scoping review. Implementation Research and Practice. https://doi.org/10.1177/2633489520988258 Plain language abstract: Provider self-efficacy is known...

Los trastornos mentales, neurológicos y por consumo de sustancias (MNS) son muy frecuentes y representan una gran carga de enfermedad y discapacidad a nivel mundial. Subsiste una amplia brecha entre la capacidad de los sistemas de salud y los recursos disponibles, entre lo que se necesita...